Mark Alfonso
5Patents
2h-index
6Co-inventors
36Inventor score
Filing activity: Nov 14, 1995 → Oct 23, 2002
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6017963A | Formulation for intranasal administration | Human Necessities | 41 | Expired |
| US6642275B2 | Formulation for respiratory tract administration | Human Necessities | 6 | Expired |
| US7018649B2 | Felodipine transdermal device and methods | Human Necessities | 2 | Expired |
| US8496960B2 | Terazosin transdermal device and methods | Human Necessities | 0 | Expired |
| US9259397B2 | Loratadine transdermal device and methods | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.